NASDAQ:CYRN - Cyren Stock Price, Forecast & News

Cyren trades on the NASDAQ under the ticker symbol "CYRN."

Cyren Ltd (NASDAQ:CYRN) announced its quarterly earnings results on Wednesday, November, 13th. The technology company reported ($0.06) earnings per share for the quarter, topping the consensus estimate of ($0.07) by $0.01. The technology company earned $9.50 million during the quarter, compared to analysts' expectations of $9.80 million. Cyren had a negative net margin of 47.56% and a negative return on equity of 68.95%. View Cyren's Earnings History.

Cyren is scheduled to release their next quarterly earnings announcement on Wednesday, February 12th 2020. View Earnings Estimates for Cyren.

1 brokers have issued 1 year price targets for Cyren's shares. Their forecasts range from $3.00 to $3.00. On average, they expect Cyren's stock price to reach $3.00 in the next twelve months. This suggests a possible upside of 134.4% from the stock's current price. View Analyst Price Targets for Cyren.

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cyren in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Cyren.

News stories about CYRN stock have trended very negative on Saturday, according to InfoTrie. The research firm ranks the sentiment of media coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Cyren earned a coverage optimism score of -3.0 on InfoTrie's scale. They also assigned news articles about the technology company a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the stock's share price in the next several days. View News Stories for Cyren.

Cyren saw a drop in short interest in the month of December. As of December 31st, there was short interest totalling 15,200 shares, a drop of 35.3% from the December 15th total of 23,500 shares. Based on an average trading volume of 31,000 shares, the days-to-cover ratio is presently 0.5 days. Approximately 0.1% of the company's stock are sold short. View Cyren's Current Options Chain.

Some companies that are related to Cyren include ChannelAdvisor (ECOM), DIRTT Environmental (DRTT), Red Violet (RDVT), eGain (EGAN), Iclick Interactive Asia Group (ICLK), Smith Micro Software (SMSI), MAM Software Group (MAMS), Inspired Entertainment (INSE), SharpSpring (SHSP), Great Elm Capital Group (GEC), Aware (AWRE), Medical Transcription Billing (MTBC), Where Food Comes From (WFCF), Mobivity (MFON) and ImageWare Systems (IWSY).

Based on aggregate information from My MarketBeat watchlists, some companies that other Cyren investors own include Actinium Pharmaceuticals (ATNM), NovaBay Pharmaceuticals (NBY), Athersys (ATHX), Biocept (BIOC), AVEO Pharmaceuticals (AVEO), Corbus Pharmaceuticals (CRBP), Inpixon (INPX), MEI Pharma (MEIP), Onconova Therapeutics (ONTX) and Pacific Ethanol (PEIX).

Shares of CYRN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of CYRN stock can currently be purchased for approximately $1.28.

Cyren has a market capitalization of $75.93 million and generates $35.90 million in revenue each year. The technology company earns $-19,410,000.00 in net income (profit) each year or ($0.31) on an earnings per share basis. Cyren employs 248 workers across the globe.View Additional Information About Cyren.

The official website for Cyren is http://www.cyren.com/.

Cyren's mailing address is 10 Ha-Menofim St. 5th Floor, Herzliya L3, 4672561. The technology company can be reached via phone at 972-9863-6888 or via email at [email protected]